For many years, syringes, pens, pumps and jet injectors have options for their diabetic insulin, now a OneTouch new device called Via could change the game.
New insulin release device for diabetics may make painful jabs History
People with type 1 diabetes and type 2 using the new system of administration of insulin OneTouch Via lunch, a la carte reported that fewer doses were lost and felt less stress on the dose compared with multiple daily injections, according a study by Calibra Medical, Inc., one of the companies Diabetes care Johnson & Johnson, at the annual conference of the American Diabetes Association (ADA).
“The new OneTouch Via is a portable system demand insulin delivery in development that allows patients to deliver discreetly, fast acting or bolus insulin at meals with the push of two buttons on the device. “
The results of the market study Acceptance Evaluation (MAE) also showed that doctors were more likely to recommend the delivery device innovative insulin for patients who are not in the goals of A1C or are new to insulin therapy fast action (RAI). The new OneTouch Via is a management system portable insulin, a la carte in development that allows patients to deliver discreetly, fast acting or bolus insulin at meals with the push of two buttons on the device, accessible even through clothing.
The water resistant, thin patch can be worn continuously for up to three days without administration providing insulin injection when necessary. “People with diabetes can often feel embarrassed or uncomfortable when they have to inject insulin at meals or eating a snack. In a social situation, may choose to miss a dose so you do not have to take themselves out of the moment, but avoiding insulin doses needed can lead to serious health complications over time, “said Dr. Brian Levy.
Levy added: “They Because the patients in the study were allowed to dose discreetly with the OneTouch Via, felt encouraged to dose more often – and ultimately, it was reported that fewer doses and better adherence to their regimen missing treatment. ” Health professionals who collaborated in the study indicated that they preferred the OneTouch Road on the two insulin pens and syringes (75 percent and 100 percent, respectively) and would be likely to recommend to their patients.
Doctors also reported that patients were to begin insulin when the previous meal due to the ease of use of the patch OneTouch Via. The study appears in the American Diabetes Association Conference (ADA).
This article was originally published on medindia.net
Posted in: health news